ID
25462
Description
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Mots-clés
Versions (2)
- 23/08/2017 23/08/2017 -
- 04/09/2017 04/09/2017 -
Téléchargé le
4 septembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
visit 3 & 4 study drug compliance starting dose of ropinirole Parkinson's Disease 101468/166
visit 3 & 4 study drug compliance starting dose of ropinirole Parkinson's Disease 101468/166
Description
Number of Visit
Alias
- UMLS CUI-1
- C1549755
Description
Return of unused study drugs
Alias
- UMLS CUI-1
- C2699071
Description
Regimen: prescribed number of tablets per day
Alias
- UMLS CUI-1
- C3166216
- UMLS CUI-2
- C0039225
- UMLS CUI-3
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Total number of tablets dispensed at last visit
Alias
- UMLS CUI-1
- C0805077
- UMLS CUI-2
- C0304229
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Total number of tablets returned at this visit
Alias
- UMLS CUI-1
- C0993159
- UMLS CUI-2
- C2699071
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Number of tablets taken by the patient (according to the diary card)
Alias
- UMLS CUI-1
- C1290952
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
TOTAL Number of tablets taken - all bottles
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Description
TOTAL Number of tablets patient should have taken ( assuming 100% compliance)
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Description
Patient's Compliance
Alias
- UMLS CUI-1
- C1321605
Description
Tablet Count
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
Description
If "No", explain below.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Description
If No, please explain
Type de données
text
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Similar models
visit 3 & 4 study drug compliance starting dose of ropinirole Parkinson's Disease 101468/166
C0039225 (UMLS CUI-2)
C0237753 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C2699071 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])